Forecast
The prognosis of hemato-oncological diseases/diseases in the blood, like the different clinical pictures, is very different. Whether a prognosis is favourable or unfavourable depends more and more on the exact changes at the genetic level and the previous diseases. With this information, the haematologist / oncologist can assess the likelihood of a cure for the haemophilia.
Special chromosomal changes even favour the healing of e.g. leukaemia, as drugs can be produced specifically to stop these cancer-promoting processes. In this sense, there is no real prophylaxis against haematological diseases. In the context of iron and vitamin deficiencies, iron and/or vitamin preparations can be taken to prevent the deficiency.
There are no prophylactic measures against the development of leukaemia, since the development of leukaemia is based on a change in the genetic make-up, which we can (not yet) influence. Some lymphoma forms develop in association with viral diseases. An example is the so-called Burkitt’s lymphoma, which can develop from a HI virus infection.
The latest research results show that more and more forms of cancer develop as a result of viral infections. However, these results are still in the early stages of research. It is important that during chemotherapy, a close control of the patient’s infection status is carried out and, if an infection is present, it is widely treated.
An untreated infection can lead to death within a few days in an immunocompromised patient. The essential part of the propylactic treatment is the therapy of chemotherapy. This means that the side effects of chemotherapy must be treated. These include the above-mentioned accompanying diseases such as kidney and liver damage. Thus, the overall therapy is not only based on the hemato-oncological treatment principles, but also on an interdisciplinary treatment principle in which many different disciplines are involved.
Summary
The haematology/teaching of diseases in the blood deals with the healthy and faulty functioning of our blood system. Haematological diseases are very versatile and complex. The most important diseases include leukaemia, lymphomas, anaemia, haemoglobin formation disorders and storage diseases.
The therapy of these diseases can be very uncomplicated on the one hand, but on the other hand it can also be very complex. Especially when it comes to the therapy of hemato-oncological diseases, such as leukaemias and lymphomas. Chemo and radiochemotherapy are important pillars of hemato-oncological therapy concepts and are nowadays indispensable when it comes to achieving curative success.
The prognosis of hematological diseases is highly variable and depends on many genetic factors. These cannot be influenced in detail. Only the information about which changes are involved is important for the therapy procedure.
Ultimately, haematology is a specialist field in which the research spectrum is far from exhausted. There will certainly be many changes in this field in the future, which will not only change haematology/oncology but also the whole of medicine.
